Gelfoam Plus - GELFOAM PLUS is an implantable hemostat supplied - BAXTER HEALTHCARE CORPORATION

Duns Number:628013963

Device Description: GELFOAM PLUS is an implantable hemostat supplied as a ready to use medical device kit cont GELFOAM PLUS is an implantable hemostat supplied as a ready to use medical device kit containing GELFOAM® Sterile Sponge, Thrombin Human lyophilized powder, two 10 mL Prefilled Saline Syringes 0.9 Percent Sodium Chloride Injection USP, and a Vial Access Device

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

1501341

Brand Name

Gelfoam Plus

Version/Model Number

1501341

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

Yes

Prescription Use (Rx)

Yes

Over the Counter (OTC)

-

Kit

-

Combination Product

Yes

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

LMF

Product Code Name

Agent, Absorbable Hemostatic, Collagen Based

Device Record Status

Public Device Record Key

530a8ae7-0cfd-4f4d-a261-22a2056c9094

Public Version Date

June 19, 2020

Public Version Number

3

DI Record Publish Date

December 21, 2017

Additional Identifiers

Package DI Number

50085412086304

Quantity per Package

6

Contains DI Package

00085412086309

Package Discontinue Date

-

Package Status

In Commercial Distribution

Package Type

CASE

"BAXTER HEALTHCARE CORPORATION" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 16
2 A medical device with a moderate to high risk that requires special controls. 101
3 A medical device with high risk that requires premarket approval 19